Backed Advanced NanoTherapies' $31M+ Series B for its dual-drug nanoparticle-coated balloon platform for vascular treatment.
JUN 2, 2026
Advanced NanoTherapies develops a functionalized nanoparticle platform for local, dual-drug delivery during catheter-based interventions
Advanced NanoTherapies develops a functionalized nanoparticle platform for local, dual-drug delivery during catheter-based interventions. SirPlux Duo is the first drug-coated balloon to deliver sirolimus and paclitaxel simultaneously through a single device, enabling controlled cellular uptake and sustained tissue retention at the lesion site. The technology is exclusively licensed from Cleveland Clinic and has received FDA Breakthrough Designation.